Home/ Supplements/ Manganese/ OsteoMove Extra Strength Joint Care

OsteoMove Extra Strength Joint Care

product on market Tablet or Pill Natural Factors Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 42% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Glucosamine sulfate and OptiMSM are supported by moderate evidence for reducing joint discomfort and improving mobility. Manganese and electrolytes provide general metabolic support, though their specific impact on joint health is less documented. The ingredient profile maintains a high safety rating for general use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for OsteoMove Extra Strength Joint Care
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
120
Servings
Other Combinations
Product Type
42%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1.5 mg (65% DV)
Within RDA (0.7× RDA) 9 studies — no high-quality reviews
Sodium
35 mg (2% DV)
Potassium
260 mg (6% DV)
Market median: 1000.0mg (1115 products) 24 studies (A:0, B:9)
OptiMSM
600 mg
Market median: 600.0mg (79 products) 25 studies (A:0, B:6)
OsteoMove Ultra Fruit Polyphenol Complex
200 mg
Market median: 375.0mg (171 products) 31 studies (A:1, B:14)
Market median: 450.0mg (254 products) 243 studies (A:0, B:100)
Market median: 20.0mg (931 products) 234 studies (A:1, B:90)
Market median: 100.0mg (173 products)
450 mcg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews

Other Ingredients

Croscarmellose Sodium Hydroxypropyl Cellulose Microcrystalline Cellulose Modified Cellulose Maltodextrin Medium Chain Triglycerides Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested usage: 2 tablets per day or as directed by a health professional.

Warnings & Precautions

Cautions: As with any supplement, consult your health professional before use if you are pregnant, breastfeeding, or trying to conceive, or if you are taking medication, have a medical condition, or anticipate a surgery.

Keep out the reach of children.

Sealed for your protection. Do not use if seal is broken.

Contains crab shell, shrimp shell, and coconut.

Formulation Notes

OsteoMove, the synergistic joint formula for support of healthy joint structure, function, and mobility, is an advanced, extra-strength option compared to our MSM Joint Formula product. Manufactured by Natural Factors to ensure safety and potency in accordance with Good Manufacturing Practices (GMP) of the FDA and Health Canada.

Contains no artificial colors, preservatives, or sweeteners; no dairy, sugar, wheat, gluten, yeast, soy, egg, fish, or GMOs.

Product of Canada

Glucosamine, Chondroitin & MSM Advanced Formulation

Promotes comfort & mobility

Additional Information

ISURA Non-GMO Mass Spec Documentation Lab tested

For freshness, store in a cool, dry place.

Recyclable container and label.

Metadata

Product Details

UPC / SKU0 68958 26841 5
DSLD Entry Date2023-01-23
Product TypeOther Combinations
FormTablet or Pill
DSLD ID282402
Data Updated2026-04-11
Research

Research Evidence

11
Research Sources
47
Avg Quality
7
Rct
2
Meta Analysis
1
Regulatory Source
C Trace elements and Alzheimer dementia in population-based studies: A bibliometric and meta-analysis
Meta Analysis Environmental pollution (Barking, Essex : 1987) 2023 PubMed DOI
C Proteins involved in iron metabolism in beef cattle are affected by copper deficiency in combination with high dietary manganese, but not by copper deficiency alone
Rct Journal of animal science 2010 PubMed DOI
C Reducing mineral usage in feedlot diets for Nellore cattle: II. Impacts of calcium, phosphorus, copper, manganese, and zinc contents on intake, performance, and liver and bone status
Rct Journal of animal science 2017 PubMed DOI
C Copper, Ceruloplasmin, Zinc, and Manganese Levels in Brain and Biological Fluids from Parkinson's Disease Patients: Systematic Review and Meta-Analysis
Meta Analysis Cells 2026 PubMed DOI
C Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group
Rct The Journal of clinical endocrinology and metabolism 2000 PubMed
C Dietary Reference Intakes: Manganese
Regulatory Source IOM/NAM Dietary Reference Intakes 2000
C Vitamins and minerals intake adequacy in hematopoietic stem cell transplant: results of a randomized controlled trial.
Rct Bone marrow transplantation PubMed DOI
C Collagen Peptides, in Association with Vitamin C, Sodium Hyaluronate, Manganese and Copper, as Part of the Rehabilitation Project in the Treatment of Chronic Low Back Pain.
Rct Endocrine, metabolic & immune disorders drug targets PubMed DOI
C Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study
Rct Military medicine 1999 PubMed
C Effects of a cream containing madecassoside, 5% panthenol, and copper-zinc-manganese on improving postlaser resurfacing wound healing: A split-face, randomized trial.
Rct Dermatologic therapy PubMed DOI
View all evidence for Manganese →
Compare

Similar Products

View all Manganese products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.